| Literature DB >> 22127831 |
Sirous Sadeghian1, Gholam Ali Kojouri, Abdonnaser Mohebbi.
Abstract
The present study was designed to compare the effects of nano red selenium and sodium selenite on the antioxidative activities of neutrophils and the hematological parameters in sheep. Fifteen sheep were randomly allocated into three groups. Groups 1 and 2 received selenium nanoparticles orally at 1 mg/kg and sodium selenite at 1 mg Se/kg for 10 consecutive days; group 3 served as the control. To assess the degrees of oxidative stress and of lipid peroxidation of the cellular membranes, the levels of thiobarbituric acid reactive substances (TBARS) were determined in serum samples that were collected at different supplementation intervals, i.e., after 0, 10, 20, and 30 days. In addition, hematological parameters in the serum samples were measured by routine procedures. It was found that TBARS levels in groups 1 and 2 were significantly higher on days 20 and 30 compared to the basal level on day 0. It was also found that on day 30, the TBARS activities in both treated groups were significantly higher than those of the controls (P < 0.05). These findings may explain the seemingly paradoxical effects of supplemental selenium on the indicators of oxidative stress, as the levels of TBARS were generally expected to decrease in the presence of selenium. There were no significant differences between the PCV and RBC values in the three groups. The white blood cell count (WBC) in group 1 showed a significant increase on days 20 and 30 in comparison with the control group. However, in group 2, there was a significant increase of the WBC value just on day 20 in comparison with the control group. Also, there were significant increases of the neutrophil counts and significant decreases of the lymphocyte counts on day 10 in group 1, in comparison with those in group 2 and controls, and on days 20 and 30 in groups 1 and 2 in comparison with those in the control group.Entities:
Mesh:
Substances:
Year: 2011 PMID: 22127831 PMCID: PMC3332341 DOI: 10.1007/s12011-011-9266-8
Source DB: PubMed Journal: Biol Trace Elem Res ISSN: 0163-4984 Impact factor: 3.738
The changes in mean + SD of TBARS value in each of the groups during the different days of sampling
| Sampling days | Group 1 (nano-selenium) | Group 2 (sodium selenite) | Control |
|---|---|---|---|
| 0 | 0.122 ± 0.006 | 0.125 ± 0.007 | 0.124 ± 0.007 |
| 10 | 0.133 ± 0.039 | 0.146 ± 0.118 | 0.135 ± 0.012 |
| 20 | 0.187 ± 0.032*,** | 0.192 ± 0.047* | 0.145 ± 0.027 |
| 30 | 0.184 ± 0.012*,**,*** | 0.199 ± 0.035*,*** | 0.141 ± 0.018 |
|
| <0.05 | <0.05 | >0.05 |
*P < 0.05, significant increase to day 0; **P < 0.05, significant increase to day 10; ***P < 0.05, significant increase to the control group
PCV counts (means ± SD) in each of the groups during the different days of sampling
| Sampling days | Group 1 (nano-selenium) | Group 2 (sodium selenite) | Control |
|---|---|---|---|
| 0 | 32.00 ± 1.225 | 30.400 ± 1.517 | 30.00 ± 2.550 |
| 10 | 33.00 ± 2.345 | 30.800 ± 2.950 | 30.400 ± 3.647 |
| 20 | 30.400 ± 1.140 | 31.600 ± 3.782 | 29.400 ± 3.050 |
| 30 | 31.800 ± 0.837 | 28.400 ± 3.286 | 29.200 ± 3.701 |
|
| >0.05 | >0.05 | >0.05 |
Red blood cell counts (means ± SD) in each of the groups during the different days of sampling
| Sampling days | Group 1 (nano-selenium) | Group 2 (sodium selenite) | Control |
|---|---|---|---|
| 0 | 11.300 ± 0.412 | 10.820 ± 0.492 | 10.660 ± 0.853 |
| 10 | 11.660 ± 0.811 | 10.900 ±0.935 | 10.820 ± 1.260 |
| 20 | 10.780 ± 0.432 | 11.220 ± 1.248 | 10.520 ± 1.040 |
| 30 | 11.240 ± 0.288 | 10.120 ± 1.117 | 10.380 ± 1.184 |
|
| >0.05 | >0.05 | >0.05 |
White blood cell counts (means ± SD) in each of the groups during the different days of sampling
| Sampling days | Group 1 (nano-selenium) | Group 2 (sodium selenit) | Control |
|---|---|---|---|
| 0 | 7,460 ± 497.996 | 7,420 ± 449.444 | 7,440 ± 602.495 |
| 10 | 8,640 ± 879.204* | 8,380 ± 785.493* | 7,560 ± 795.613 |
| 20 | 9,020 ± 491.935*,** | 8,540 ± 931.665*,** | 7,420 ± 521.536 |
| 30 | 8,580 ± 349.285*,** | 8,100 ± 768.115 | 7,500 ± 768.115 |
|
| <0.05 | <0.05 | >0.05 |
*P < 0.05, significant increase to day 0; **P < 0.05, significant increase to the control group
Neutrophil counts (means ± SD) in each of the groups during the different days of sampling
| Sampling days | Group 1 (nano-selenium) | Group 2 (sodium selenite) | Control |
|---|---|---|---|
| 0 | 33.200 ± 1.924 | 32.400 ± 1.817 | 34.200 ± 2.864 |
| 10 | 43.200 ± 3.701*,***,**** | 37.800 ± 3.701* | 35.00 ± 7.00 |
| 20 | 63.00 ± 10.840*,**,**** | 55.200 ± 8.289*,**,**** | 36.400 ± 1.517 |
| 30 | 53.800 ± 6.686*,**,**** | 44.600 ± 6.387*,**** | 34.400 ± 2.510 |
|
| <0.05 | <0.05 | >0.05 |
*P < 0.05, significant increase to day 0; **P < 0.05, significant increase to day 10; ***P < 0.05, significant increase to group 2 (sodium selenite); ****P < 0.05, significant increase to the control group
Lymphocyte counts (means ± SD) in each of the groups during the different days of sampling
| Sampling days | Group 1 (nano-selenium) | Group 2 (sodium selenite) | Control |
|---|---|---|---|
| 0 | 63.800 ± 1.924 | 65.400 ± 0.894 | 63.800 ± 2.588 |
| 10 | 53.600 ± 3.507*,****,***** | 59.800 ± 2.168* | 62.200 ± 6.723 |
| 20 | 34.200 ± 10.498*,**,***** | 41.800 ± 9.230*,**,***** | 61.800 ± 2.775 |
| 30 | 34.200 ± 10.498*,**,***** | 53.400 ± 6.107*,***,***** | 63.600 ± 2.881 |
|
| <0.05 | <0.05 | >0.05 |
*P < 0.05, significant reduction to day 0; **P < 0.05, significant reduction to day 10; ***P < 0.05, significant increase to day 20; ****P < 0.05, significant reduction to group 2 (sodium selenite); *****P < 0.05, significant reduction to the control group